Literature DB >> 32861787

Normative vs. patient-specific brain connectivity in deep brain stimulation.

Qiang Wang1, Harith Akram2, Muthuraman Muthuraman3, Gabriel Gonzalez-Escamilla3, Sameer A Sheth4, Simón Oxenford5, Fang-Cheng Yeh6, Sergiu Groppa3, Nora Vanegas-Arroyave7, Ludvic Zrinzo2, Ningfei Li5, Andrea Kühn5, Andreas Horn5.   

Abstract

Brain connectivity profiles seeding from deep brain stimulation (DBS) electrodes have emerged as informative tools to estimate outcome variability across DBS patients. Given the limitations of acquiring and processing patient-specific diffusion-weighted imaging data, a number of studies have employed normative atlases of the human connectome. To date, it remains unclear whether patient-specific connectivity information would strengthen the accuracy of such analyses. Here, we compared similarities and differences between patient-specific, disease-matched and normative structural connectivity data and their ability to predict clinical improvement. Data from 33 patients suffering from Parkinson's Disease who underwent surgery at three different centers were retrospectively collected. Stimulation-dependent connectivity profiles seeding from active contacts were estimated using three modalities, namely patient-specific diffusion-MRI data, age- and disease-matched or normative group connectome data (acquired in healthy young subjects). Based on these profiles, models of optimal connectivity were calculated and used to estimate clinical improvement in out of sample data. All three modalities resulted in highly similar optimal connectivity profiles that could largely reproduce findings from prior research based on this present novel multi-center cohort. In a data-driven approach that estimated optimal whole-brain connectivity profiles, out-of-sample predictions of clinical improvements were calculated. Using either patient-specific connectivity (R = 0.43 at p = 0.001), an age- and disease-matched group connectome (R = 0.25, p = 0.048) and a normative connectome based on healthy/young subjects (R = 0.31 at p = 0.028), significant predictions could be made. Our results of patient-specific connectivity and normative connectomes lead to similar main conclusions about which brain areas are associated with clinical improvement. Still, although results were not significantly different, they hint at the fact that patient-specific connectivity may bear the potential of explaining slightly more variance than group connectomes. Furthermore, use of normative connectomes involves datasets with high signal-to-noise acquired on specialized MRI hardware, while clinical datasets as the ones used here may not exactly match their quality. Our findings support the role of DBS electrode connectivity profiles as a promising method to investigate DBS effects and to potentially guide DBS programming.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Deep brain stimulation; Human connectome; Parkinson's disease; Subthalamic nucleus; Tractography

Year:  2020        PMID: 32861787     DOI: 10.1016/j.neuroimage.2020.117307

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  16 in total

1.  Identifying the neural network for neuromodulation in epilepsy through connectomics and graphs.

Authors:  Artur Vetkas; Jürgen Germann; Gavin Elias; Aaron Loh; Alexandre Boutet; Kazuaki Yamamoto; Can Sarica; Nardin Samuel; Vanessa Milano; Anton Fomenko; Brendan Santyr; Jordy Tasserie; Dave Gwun; Hyun Ho Jung; Taufik Valiante; George M Ibrahim; Richard Wennberg; Suneil K Kalia; Andres M Lozano
Journal:  Brain Commun       Date:  2022-04-06

2.  A Functional Connectome of Parkinson's Disease Patients Prior to Deep Brain Stimulation: A Tool for Disease-Specific Connectivity Analyses.

Authors:  Aaron Loh; Alexandre Boutet; Jürgen Germann; Bassam Al-Fatly; Gavin J B Elias; Clemens Neudorfer; Jillian Krotz; Emily H Y Wong; Roohie Parmar; Robert Gramer; Michelle Paff; Andreas Horn; J Jean Chen; Paula Azevedo; Alfonso Fasano; Renato P Munhoz; Mojgan Hodaie; Suneil K Kalia; Walter Kucharczyk; Andres M Lozano
Journal:  Front Neurosci       Date:  2022-06-24       Impact factor: 5.152

3.  Tuber Locations Associated with Infantile Spasms Map to a Common Brain Network.

Authors:  Alexander L Cohen; Brechtje P F Mulder; Anna K Prohl; Louis Soussand; Peter Davis; Mallory R Kroeck; Peter McManus; Ali Gholipour; Benoit Scherrer; E Martina Bebin; Joyce Y Wu; Hope Northrup; Darcy A Krueger; Mustafa Sahin; Simon K Warfield; Michael D Fox; Jurriaan M Peters
Journal:  Ann Neurol       Date:  2021-01-21       Impact factor: 10.422

4.  Impact of brain shift on neural pathways in deep brain stimulation: a preliminary analysis via multi-physics finite element models.

Authors:  Ma Luo; Saramati Narasimhan; Paul S Larson; Alastair J Martin; Peter E Konrad; Michael I Miga
Journal:  J Neural Eng       Date:  2021-04-06       Impact factor: 5.043

5.  Seed-Based Connectivity Prediction of Initial Outcome of Subthalamic Nuclei Deep Brain Stimulation.

Authors:  Yingchuan Chen; Guanyu Zhu; Defeng Liu; Yuye Liu; Xin Zhang; Tingting Du; Jianguo Zhang
Journal:  Neurotherapeutics       Date:  2022-03-23       Impact factor: 6.088

6.  Connectivity Patterns of Deep Brain Stimulation Targets in Patients with Gilles de la Tourette Syndrome.

Authors:  Petra Heiden; Mauritius Hoevels; Dilruba Bayram; Juan C Baldermann; Thomas Schüller; Daniel Huys; Veerle Visser-Vandewalle; Pablo Andrade
Journal:  Brain Sci       Date:  2021-01-11

7.  Proceedings of the Eighth Annual Deep Brain Stimulation Think Tank: Advances in Optogenetics, Ethical Issues Affecting DBS Research, Neuromodulatory Approaches for Depression, Adaptive Neurostimulation, and Emerging DBS Technologies.

Authors:  Vinata Vedam-Mai; Karl Deisseroth; James Giordano; Gabriel Lazaro-Munoz; Winston Chiong; Nanthia Suthana; Jean-Philippe Langevin; Jay Gill; Wayne Goodman; Nicole R Provenza; Casey H Halpern; Rajat S Shivacharan; Tricia N Cunningham; Sameer A Sheth; Nader Pouratian; Katherine W Scangos; Helen S Mayberg; Andreas Horn; Kara A Johnson; Christopher R Butson; Ro'ee Gilron; Coralie de Hemptinne; Robert Wilt; Maria Yaroshinsky; Simon Little; Philip Starr; Greg Worrell; Prasad Shirvalkar; Edward Chang; Jens Volkmann; Muthuraman Muthuraman; Sergiu Groppa; Andrea A Kühn; Luming Li; Matthew Johnson; Kevin J Otto; Robert Raike; Steve Goetz; Chengyuan Wu; Peter Silburn; Binith Cheeran; Yagna J Pathak; Mahsa Malekmohammadi; Aysegul Gunduz; Joshua K Wong; Stephanie Cernera; Wei Hu; Aparna Wagle Shukla; Adolfo Ramirez-Zamora; Wissam Deeb; Addie Patterson; Kelly D Foote; Michael S Okun
Journal:  Front Hum Neurosci       Date:  2021-04-19       Impact factor: 3.169

Review 8.  Novel targeted therapies for Parkinson's disease.

Authors:  Theodora Ntetsika; Paraskevi-Evita Papathoma; Ioanna Markaki
Journal:  Mol Med       Date:  2021-02-25       Impact factor: 6.354

9.  White matter variability, cognition, and disorders: a systematic review.

Authors:  Stephanie J Forkel; Patrick Friedrich; Michel Thiebaut de Schotten; Henrietta Howells
Journal:  Brain Struct Funct       Date:  2021-11-03       Impact factor: 3.270

10.  Network Substrates of Centromedian Nucleus Deep Brain Stimulation in Generalized Pharmacoresistant Epilepsy.

Authors:  Cristina V Torres Diaz; Gabriel González-Escamilla; Dumitru Ciolac; Marta Navas García; Paloma Pulido Rivas; Rafael G Sola; Antonio Barbosa; Jesús Pastor; Lorena Vega-Zelaya; Sergiu Groppa
Journal:  Neurotherapeutics       Date:  2021-04-26       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.